Expansion and Strengthening of Clinic-Based HIV Related Services in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 153003CONT17

Opportunity Information: Apply for CDC RFA GH15 153003CONT17

The grant opportunity titled "Expansion and Strengthening of Clinic-Based HIV Related Services in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. government funding action administered by the Department of Health and Human Services (HHS), specifically the Centers for Disease Control and Prevention (CDC) within the Center for Global Health (CGH). It is positioned within the public health domain and is tied directly to PEPFAR, the U.S. initiative focused on controlling and ultimately ending the HIV epidemic through prevention, treatment, and health system strengthening in heavily affected countries, including Haiti.

This opportunity is identified by the funding opportunity number "CDC RFA GH15-153003CONT17" and is categorized as "Continuation" funding. In practical terms, that means it is structured to continue and build on existing CDC-supported work rather than launching an entirely new, open-ended competition from scratch. Continuation opportunities are often used when CDC wants to sustain progress, expand coverage, improve quality, and deepen impact under an established programmatic framework, usually with implementing partners that already have operational capacity and a track record delivering HIV services in-country. The funding instrument is a Cooperative Agreement, which is important because it signals substantial involvement by CDC in the program. Under a cooperative agreement, CDC typically provides not only funding but also ongoing technical direction, collaboration on program design and performance monitoring, and alignment with national strategies and PEPFAR targets.

The focus of the award is clinic-based HIV-related services in Haiti, with an emphasis on both expansion (reaching more people, more sites, or more geographic areas) and strengthening (improving the quality, efficiency, and reliability of services already being delivered). While the short description provided does not list specific activities, clinic-based HIV service strengthening under PEPFAR and CDC commonly includes improving HIV testing services and linkage to care; ensuring timely initiation and continuity of antiretroviral therapy (ART); enhancing viral load monitoring and use of results to improve clinical outcomes; strengthening retention strategies so patients remain in care; improving prevention and management of opportunistic infections and co-morbidities; supporting prevention interventions delivered in clinical settings (including prevention counseling and services for people at higher risk); and improving data systems, case-based surveillance, and routine program monitoring to support performance-based decision-making. In Haiti specifically, clinic strengthening often intersects with laboratory networks, supply chain and commodity management, clinical mentoring and training, quality improvement initiatives, and coordination with the Ministry of Public Health and Population and other PEPFAR partners to avoid duplication and close coverage gaps.

The opportunity falls under the broader funding activity category of Health and is associated with the CFDA number 93.067, which corresponds to CDC global HIV/AIDS activities. The eligibility listing shows "Others (see text field entitled Additional Information on Eligibility for clarification)," which indicates that eligibility is not limited to a single applicant type in the basic summary and would be defined more precisely in the full announcement package. In similar CDC continuation cooperative agreements, eligible applicants often include a mix of organizations such as non-profits, non-governmental organizations, universities, and potentially other entities with demonstrated capacity to implement HIV programs, manage U.S. federal awards, and operate in Haiti.

Timing details in the notice show a creation date of February 8, 2017, with an original closing date of April 11, 2017. That roughly two-month window suggests a standard application period for a federal assistance announcement, during which applicants would be expected to submit a program narrative, work plan, budget, and supporting documentation demonstrating technical approach, management capacity, monitoring and evaluation plans, and alignment with PEPFAR and national HIV priorities.

The award information lists an expected number of awards of 10, indicating that CDC anticipated supporting multiple implementing partners or multiple streams of work under this continuation action, likely to cover different service delivery networks, geographic areas, or complementary technical scopes within Haiti's HIV response. The award ceiling is listed as 0, which typically means the ceiling amount was not specified in the brief summary record or would be defined in the full funding announcement or negotiated based on availability of funds, program needs, and approved budgets. In federal listings, a "0" ceiling should not be interpreted as no funding; it is more commonly a placeholder when the ceiling is not published in the summary extract.

Overall, the opportunity is best understood as a CDC-led, PEPFAR-funded cooperative agreement intended to sustain and improve Haiti's clinic-based HIV service delivery platform by increasing reach and strengthening quality and system performance, with CDC playing an active technical partnership role and multiple awards anticipated to support a coordinated national impact.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Expansion and Strengthening of Clinic-Based HIV Related Services in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 08, 2017.
• Applicants must submit their applications by Apr 11, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 153003CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: